Preclinical pharmacology of the novel oral dual histamine H1 and H3 receptor antagonist GSK835726

被引：0
|
作者：
Ford, A. [1 ]
Browning, C. [1 ]
Russell, L. [1 ]
Saunders, K. [1 ]
Hall, D. [1 ]
Morrison, V [1 ]
Changani, K. [1 ]
Hodgson, S. [2 ]
Connor, H. [1 ]
Clark, K. [1 ]
机构：
[1] GlaxoSmithKline R&D, Resp Biol, Stevenage, Herts, England
[2] GlaxoSmithKline R&D, Med Chem, Stevenage, Herts, England
来源：
ALLERGY | 2009年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
145
引用
收藏
页码：69 / 69
页数：1
相关论文
共 50 条
  • [41] Opposite functions of histamine H1 and H2 receptors and H3 receptor in substantia nigra pars reticulata
    Zhou, Fu-Wen
    Xu, Jian-Jun
    Zhao, Yu
    LeDoux, Mark S.
    Zhou, Fu-Ming
    JOURNAL OF NEUROPHYSIOLOGY, 2006, 96 (03) : 1581 - 1591
  • [42] Effects of histamine H1, H2 and H3 receptor antagonists on bone mechanical properties in female rats
    Folwarczna, J.
    Sliwinski, L.
    Pytlik, M.
    Janas, A.
    BONE, 2011, 48 : S193 - S193
  • [43] Preclinical evaluation of the abuse potential of Pitolisant, a histamine H3 receptor inverse agonist/antagonist compared with Modafinil
    Uguen, M.
    Perrin, D.
    Belliard, S.
    Ligneau, X.
    Beardsley, P. M.
    Lecomte, J. M.
    Schwartz, J. C.
    BRITISH JOURNAL OF PHARMACOLOGY, 2013, 169 (03) : 632 - 644
  • [44] The ameliorating effects of NMDA receptor agonists on histamine H1 antagonist-induced memory and hippocampal theta disruptions are prevented by the H3 receptor agonist in rats
    Masuoka, Takayoshi
    Kamei, Chiaki
    BRAIN RESEARCH BULLETIN, 2009, 79 (06) : 422 - 425
  • [45] CONCERNING HISTAMINE RECEPTOR (H1)
    ROCHA, M
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 1969, 21 (11) : 778 - +
  • [46] Histamine H3 receptor agonists
    De Esch, IJP
    Belzar, KJ
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2004, 4 (09) : 955 - 963
  • [47] Novel dual acting molecules possessing 5-lipoxygenase enzyme inhibition and histamine H1 receptor antagonist properties
    R. T. Scannell
    M. P. Arrington
    L. Bayless
    X. Cai
    J. B. Eckman
    M. Eckert
    D. G. Ene
    J. L. Ellis
    S. Hussoin
    G. M. Latham
    T. A. Lewis
    L. Libertine
    J. Nicolas
    W. M. Selig
    C. E. Schwartz
    B. F. Wels
    D. M. Wypij
    M. A. Young
    D. Zou
    Inflammation Research, 2004, 53 : S33 - S34
  • [48] Histamine H3 receptor antagonists
    Tozer, MJ
    Kalindjian, SB
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2000, 10 (07) : 1045 - 1055
  • [49] Novel dual acting molecules possessing 5-lipoxygenase enzyme inhibition and histamine H1 receptor antagonist properties
    Scannell, RT
    Arrington, MP
    Bayless, L
    Cai, X
    Eckman, JB
    Eckert, M
    Ene, DG
    Ellis, JL
    Hussoin, S
    Latham, GM
    Lewis, TA
    Libertine, L
    Nicolas, J
    Selig, WM
    Schwartz, CE
    Wels, BF
    Wypij, DM
    Young, MA
    Zou, D
    INFLAMMATION RESEARCH, 2004, 53 (Suppl 1) : S33 - S34
  • [50] The histamine H3 receptor: from gene cloning to H3 receptor drugs
    Rob Leurs
    Remko A. Bakker
    Henk Timmerman
    Iwan J. P. de Esch
    Nature Reviews Drug Discovery, 2005, 4 : 107 - 120
12345